Stockreport

Moderna: V940/Keytruda Data And Vaccine Revenues Drive A High-Risk Recovery Story [Seeking Alpha]

Moderna, Inc.  (MRNA) 
Last moderna, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: marinabio.com/investor-relations
PDF 2026 is pivotal, with multiple oncology catalysts—especially Intismeran/Keytruda Phase II and III readouts—potentially driving future revenue and valuation. MRNA main [Read more]